A common molecular variant of angiotensinogen (AGT), the precursor of the potent vasoactive hormone angiotensin II, has been incriminated as a marker for a genetic predisposition to essential hypertension in Caucasians (Jeunemaitre, X., F. Soubrier, Y. V. Kotelevtsev, R. P. Lifton, C. S. Williams, A. Charru, S. C. Hunt, P. N. Hopkins, R. R. Williams, J. M. Lalouel, and P. Corvol. 1992. Cell. 71:169-180). We now show that the same variant, T235, is associated with essential hypertension in Japanese patients. The observation of this association in a distinct, ethnically homogeneous population further substantiates an involvement of angiotensinogen in the pathogenesis of essential hypertension and has physiological, epidemiological, and evolutionary implications. (J. Clin. Invest.
Introduction
Essential hypertension is a major public health concern in Japan, where its high prevalence accounts for one of the highest rates ofcerebrovascular accidents in the world ( 1, 2) . It is often advanced that the particular features of the epidemiology of essential hypertension and its vascular complications in Japan result from the high level of sodium intake in this population (3, 4) .
The well-documented familial aggregation of essential hypertension supports the hypothesis that genetic factors contribute to its determination (5) . The renin-angiotensin system is a prime suspect for harboring genetic determinants of hypertension, as it plays a cardinal role in salt and water homeostasis and in the maintenance of vascular tone (6) . Renin cleaves angiotensinogen to generate angiotensin I, which, after further cleavage by the angiotensin-converting enzyme, yields angiotensin II, a peptide hormone that promotes vasoconstriction and sodium retention.
An involvement of angiotensinogen in the pathogenesis of essential hypertension was suggested recently (7) . This conclusion rested on the observation of genetic linkage in hypertensive siblings, of a higher occurrence of two molecular variants ofthe angiotensinogen gene (AGT) in hypertensive cases compared with controls, and of higher plasma concentrations of angiotensinogen in subjects carrying the most common AGT variant, T235. These findings were established in two independent series of Caucasian subjects, one from Salt Lake City and the other from Paris. In a separate study, T235 was found to occur at higher frequency among preeclamptic women than among women with normal pregnancies (8) . The association with preeclampsia was observed in two independent samples: Caucasian women ascertained in Utah, and Japanese women ascertained in Japan. Variant T235 corresponds to the presence of a threonine instead of a methionine at residue 235 of the mature protein and occurs at a frequency of 35-40% in Caucasians (7) . Another variant, M 174, is characterized by the presence ofa methionine instead of a threonine at residue 174; occurring at a frequency of 8-10% in Caucasians, it also exhibits significant association with hypertension (7). However, it is found only in genes encoding the T235 variant and does not behave as an independent predictor of risk (1, 7) .
We now report that the AGT variant T235 occurs at higher frequency in essential hypertensive subjects than in normotensive controls in Japan. Furthermore, its population frequency is higher among Japanese than among Caucasian subjects. Possible implications of these observations are discussed.
Methods
Subjects. Patients with essential hypertension were ascertained at the Hypertension Clinics of the Yamanashi Medical University and the Nagoya City University Hospitals. The following selection criteria were applied: (a) established hypertension defined by a systolic blood pressure (BP)' > 160 mmHg and/or a diastolic BP > 95 mmHg; (b) absence ofsecondary hypertension; (c) absence of renal disease and renal insufficiency; and (d) absence ofdiabetes mellitus. This yielded a series of 105 cases with a mean current age of 61 yr. The 81 normotensive controls were collected in Yamanashi Medical University. They included healthy college students, physicians, and other staffmembers or patients who visited the same clinic but presented no serious illness.
They had systolic and diastolic BP < 140 and 90 mmHg, respectively, no previous history of high blood pressure, and no renal disease or diabetes. Their age varied from 16 to 78 yr, with a mean of 34 yr.
Genotyping. Genotypes at residues 174 and 235 ofAGTwere deter-specific oligonucleotides previously described (7). Genomic DNA was extracted from 1.0 ml of whole blood using GENOMIX kits (Talent, pertension later in life. Lastly, the association observed between T235 and pregnancy-induced hypertension in a sample of 41 Japanese women (8) provides independent corroboration. A previous report (7) documented an association between plasma angiotensinogen and AGT genotypes at residue 235. Regrettably, the protocols for sample collection and storage used in this study precluded the accurate determination of plasma angiotensinogen concentrations by the indirect method. Although the pathophysiological significance of this association remains unclear, it would be of interest to test whether it is also observed among Japanese hypertensive subjects.
The association of T235 with hypertension in Japanese as well as in Caucasians suggests that this allele may behave as a global risk factor in humans. From the evidence obtained thus far, however, one cannot determine whether T235 exerts this effect directly, or whether it serves as a marker for one or more molecular variants of AGT that remain to be identified. The variant T235 was initially denoted M235T (7) because a methionine occurred at residue 235 in the first published DNA sequence of AGT (10) and because it occurred at higher frequency in the Caucasian subjects examined at the time. We have now observed that T235 is more common than M235 in all other ethnic groups examined, including Japanese, AfricanAmericans, American Hispanics, and Native American (our unpublished observations). When a multiallelic DNA marker ofAGTwas examined (7) , it was found that M235 occurred in association with a much more restricted range ofmarker alleles than T235. Together, these observations raise the possibility that T235 marks the original form of the gene.
The high frequency ofT235 and the low prevalence ofother risk factors such as obesity and atherosclerosis in Japan suggest that an AGT-related predisposition may contribute to a greater proportion of hypertensive cases among Japanese than among Caucasians. Under this hypothesis, cerebrovascular accidents may be a feature of the clinical course of AGT-dependent hypertension.
Because of the involvement of angiotensinogen in salt homeostasis, T235 may be a marker for a salt-sensitive form of essential hypertension. Epidemiological studies have documented a striking gradient of increasing prevalence of hypertension and stroke mortality from South to North Japan (11) , which correlates with a parallel rise in average daily salt intake (4) . In Japan as elsewhere, attempts to correlate individual salt intake with blood pressure within populations have yielded inconsistent results (12, 13) . However, such studies have too little power to reveal an effect of the magnitude predicted by contrasts among populations (14) , and commonly used assessments such as a single 24-h urine collection are poor indices of usual sodium intake (15, 16) . Physiological studies with molec- Xi2= 11.29 Alleles are designated as A (M235) and a (T235), respectively. ular markers of angiotensinogen may resolve these fundamental issues.
